Now showing items 1-1 of 1

    • Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value. 

      Abaasa, A; Hendrix, C; Gandhi, M; Anderson, P; Kamali, A; Kibengo, F; Sanders, E; Mutua, G; Bumpus, NN; Priddy, F; Haberer, JE (University of Nairobi, 2017)
      Measuring PrEP adherence remains challenging. In 2009-2010, the International AIDS Vaccine Initiative randomized phase II trial participants to daily tenofovir disoproxil fumarate/emtricitabine or placebo in Uganda and ...